CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 221 enrolled
Drug / intervention
Text2Breathe Study Groupbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03032159
NCT03032159N/ACompleted

Text2Breathe: Enhance Parent Communication to Reduce Pediatric Asthma Disparities

Seattle Children's Hospital·interventional·Posted Jan 26, 2017·Updated Dec 3, 2024

In Brief

A clinical study evaluating Text2Breathe Study Group for Asthma. Completed, enrolled 221 participants across 2 sites.

Detailed Summary

Text2Breathe (T2B) is a randomized controlled trial aimed at improving communication between parents and their children's' primary care providers about asthma. The overarching goal of this study is to reduce disparities among a population with high rates of pediatric asthma morbidity. The investigators are testing the efficacy of a short message service (SMS)-enhanced health communication (HC) intervention ("Text2Breathe") designed to equip urban, low-income parents with tools for communicating effectively with their children's primary care provider (PCP).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 26, 2017
Enrollment StartAug 1, 2015
Primary CompletionMar 1, 2020
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 9.4 years ago

Interventions

Text2Breathe Study Groupbehavioral